KRAS G12C (41%), KRAS G12V (22%), KRAS G12D (12%), and KRAS G12A (9.3%) represent the most commonly observed mutations in KRAS within lung cancers (7, 27). This evidence concerns the gene KRAS and lung carcinoma.